ketanserin has been researched along with Hyperplasia in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intimal hyperplasia is considered to be the result of smooth muscle cell proliferation." | 5.29 | Reduction of experimental vein graft intimal hyperplasia by ketanserin. ( Barber, L; Davies, MG; Hagen, PO; Klyachkin, ML; Massey, MF; McCann, RL; Schwartz, LB; Svendsen, E, 1993) |
| "Intimal hyperplasia is considered to be the result of smooth muscle cell proliferation." | 1.29 | Reduction of experimental vein graft intimal hyperplasia by ketanserin. ( Barber, L; Davies, MG; Hagen, PO; Klyachkin, ML; Massey, MF; McCann, RL; Schwartz, LB; Svendsen, E, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Massey, MF | 1 |
| Davies, MG | 1 |
| Svendsen, E | 1 |
| Klyachkin, ML | 1 |
| Schwartz, LB | 1 |
| Barber, L | 1 |
| McCann, RL | 1 |
| Hagen, PO | 1 |
1 other study available for ketanserin and Hyperplasia
| Article | Year |
|---|---|
Reduction of experimental vein graft intimal hyperplasia by ketanserin.
Topics: Animals; Hyperplasia; Ketanserin; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Rabb | 1993 |